Clinical Trial Update: Phase I/II Study of DFP-10917 in Patients With Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for DFP-10917 in acute leukemia (AML and ALL) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ac Acute Lymphocytic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• DFP-10917

Snippet

Sponsor: Delta-Fly Pharma, Inc. | Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED